Mitophagy helps blood cancer cells to evade the killing effe

Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often adopt features that let them evade the drugs' effects within a year.

Related Keywords

United States , United Kingdom , Cambridge , Cambridgeshire , New York , Texas , Houston , Americans , Emily Henderson , Iannis Aifantis , Bing Carter , Hermannm Biggs , Michael Andreeff , Jo Ishizawa , Kun Wang , Dimitrios Papaioannou , Soobeom Lee , Michael Cammer , Malgorzata Anna Zal , Evripidis Gavathiotis , Xufeng Chen , Zhengxi Sun , Emmanouil Zacharioudakis , Hua Zhou , Raoul Tibes , Audrey Lasry , Bettina Nadorp , Wafa Al Santli , Christina Glytsou , Aristotelis Tsirigos , Tomasz Zal , Langone Health , Rutgers University , National Institutes Of Health , Department Of Pathology , Leukemia Lymphoma Society , Astrazeneca , Perlmutter Cancer Center , Grossman School Of Medicine , University Of Texas Md Anderson Cancer Center , Albert Einstein College Of Medicine , Cancer Discovery , National Institutes , Lymphoma Society , Albert Einstein College , Cancer Center , Blood , Blood Cancer , Dancer , Acute Myeloid Leukemia , One , Bone Marrow , Fell , Ell Death , Chloroquine , Drugs , Genes , Leukemia , Lymphoma , Medicine , Itochondria , Myeloid Leukemia , Pathology , Programmed Cell Death , Research ,